Bone marrow progenitor cells from CREB transgenic mice had increased proliferative capacity and were hypersensitive to growth factors compared to normal hematopoietic stems cells (HSCs).
This study, which has ended, found that the mobilization and harvesting of bone marrow progenitor cells from persons infected with HIV-1 induced a transient increase in viral replication in some patients but was not associated with adverse effects [ 137, 138].
To avoid the disadvantages that come with autologous bone transfer, such as a second surgical site and an increase in postoperative pain, biomaterial research has focused on the development of bone substitute materials that serve as scaffolds for the ingrowth of bone and its progenitor cells from the surrounding tissue [9].
The cells analysed from alveolar bone chips derive from progenitor cells from periodontal ligament lining the bone surface (including Sharpey's fibres), or marrow cavities exposed as a consequence of preparing small bone chips.
NT-020 was shown to stimulate the proliferation of human stem cells derived from bone marrow; bone marrow derived CD34+ and progenitor cells from peripheral blood (CD133+) in vitro [14].
Microfracture chondroplasty consists of the penetration of the subchondral bone with the subsequent release of progenitor cells from the bone marrow cavity into the defect.
Various approaches have been developed differing either in the choice of scaffold (synthetic biodegradable polymers, decellularised xeno- or homografts) or cell source for the production of living tissue (vascular derived cells, bone marrow cells or progenitor cells from the peripheral blood).
As a single-stage procedure, the most used treatment of focal cartilage defects represents the microfracture (Mfx) technique in which a penetration of the subchondral bone layer is performed with subsequent effluent of progenitor cells from the bone marrow into the articular cartilage lesion [ 1, 2, 8].
Using this assay we previously found that NT-020 could promote proliferation of bone marrow and bone marrow derived CD34+ progenitors and progenitor cells from peripheral blood (CD133+) in vitro [14].
Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures.
